These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23176755)

  • 1. Vigilance decrement during the on-the-road driving tests: the importance of time-on-task in psychopharmacological research.
    Verster JC; Roth T
    Accid Anal Prev; 2013 Sep; 58():244-8. PubMed ID: 23176755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence and nature of stopped on-the-road driving tests and the relationship with objective performance impairment.
    Verster JC; Roth T
    Accid Anal Prev; 2012 Mar; 45():498-506. PubMed ID: 22269535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function.
    Kuypers KP; Samyn N; Ramaekers JG
    Psychopharmacology (Berl); 2006 Sep; 187(4):467-75. PubMed ID: 16830130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of on-the-road experimental studies of hypnotics: effects of time after intake, dose, and half-life.
    Roth T; Eklov SD; Drake CL; Verster JC
    Traffic Inj Prev; 2014; 15(5):439-45. PubMed ID: 24678565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.
    Verster JC; Volkerts ER; Schreuder AH; Eijken EJ; van Heuckelum JH; Veldhuijzen DS; Verbaten MN; Paty I; Darwish M; Danjou P; Patat A
    J Clin Psychopharmacol; 2002 Dec; 22(6):576-83. PubMed ID: 12454557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validating lane drifts as a predictive measure of drug or sleepiness induced driving impairment.
    Vinckenbosch FRJ; Vermeeren A; Verster JC; Ramaekers JG; Vuurman EF
    Psychopharmacology (Berl); 2020 Mar; 237(3):877-886. PubMed ID: 31897572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of central nervous system drugs on driving: speed variability versus standard deviation of lateral position as outcome measure of the on-the-road driving test.
    Verster JC; Roth T
    Hum Psychopharmacol; 2014 Jan; 29(1):19-24. PubMed ID: 24375715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.
    Ramaekers JG
    J Clin Psychiatry; 2003 Jan; 64(1):20-9. PubMed ID: 12590619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the effects of oxazepam and diazepam in actual highway driving and neurocognitive test performance: a validation study.
    Jongen S; Vuurman EFPM; Ramaekers JG; Vermeeren A
    Psychopharmacology (Berl); 2018 Apr; 235(4):1283-1294. PubMed ID: 29500585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the effects of carbamazepine and the NMDA receptor antagonist remacemide on road tracking and car-following performance in actual traffic.
    Ramaekers G; Lamers J; Verhey F; Muntjewerff D; Mobbs E; Sanders N; Lewis M; Lockton A
    Psychopharmacology (Berl); 2002 Jan; 159(2):203-10. PubMed ID: 11862350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study.
    van de Loo AJAE; Bervoets AC; Mooren L; Bouwmeester NH; Garssen J; Zuiker R; van Amerongen G; van Gerven J; Singh J; der Ark PV; Fedgchin M; Morrison R; Wajs E; Verster JC
    Psychopharmacology (Berl); 2017 Nov; 234(21):3175-3183. PubMed ID: 28755104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicinal Δ(9) -tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests.
    Bosker WM; Kuypers KP; Theunissen EL; Surinx A; Blankespoor RJ; Skopp G; Jeffery WK; Walls HC; van Leeuwen CJ; Ramaekers JG
    Addiction; 2012 Oct; 107(10):1837-44. PubMed ID: 22553980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of alprazolam on driving ability, memory functioning and psychomotor performance: a randomized, placebo-controlled study.
    Verster JC; Volkerts ER; Verbaten MN
    Neuropsychopharmacology; 2002 Aug; 27(2):260-9. PubMed ID: 12093599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly.
    Vermeeren A; Vets E; Vuurman EF; Van Oers AC; Jongen S; Laethem T; Heirman I; Bautmans A; Palcza J; Li X; Troyer MD; Wrishko R; McCrea J; Sun H
    Psychopharmacology (Berl); 2016 Sep; 233(18):3341-51. PubMed ID: 27424295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of driving simulator performance with real driving after alcohol intake: a randomised, single blind, placebo-controlled, cross-over trial.
    Helland A; Jenssen GD; Lervåg LE; Westin AA; Moen T; Sakshaug K; Lydersen S; Mørland J; Slørdal L
    Accid Anal Prev; 2013 Apr; 53():9-16. PubMed ID: 23357031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and subchronic effects of amitriptyline 25mg on actual driving in chronic neuropathic pain patients.
    Veldhuijzen DS; van Wijck AJ; Verster JC; Kenemans JL; Kalkman CJ; Olivier B; Volkerts ER
    J Psychopharmacol; 2006 Nov; 20(6):782-8. PubMed ID: 16401650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged nocturnal driving can be as dangerous as severe alcohol-impaired driving.
    Verster JC; Taillard J; Sagaspe P; Olivier B; Philip P
    J Sleep Res; 2011 Dec; 20(4):585-8. PubMed ID: 21226780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing a vigilance decrement in aged rats: effects of pre-feeding, task manipulation, and psychostimulants.
    Grottick AJ; Higgins GA
    Psychopharmacology (Berl); 2002 Oct; 164(1):33-41. PubMed ID: 12373417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting psychopharmacological drug effects on actual driving performance (SDLP) from psychometric tests measuring driving-related skills.
    Verster JC; Roth T
    Psychopharmacology (Berl); 2012 Mar; 220(2):293-301. PubMed ID: 21922169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and subchronic effects of bilastine (20 and 40 mg) and hydroxyzine (50 mg) on actual driving performance in healthy volunteers.
    Conen S; Theunissen EL; Van Oers AC; Valiente R; Ramaekers JG
    J Psychopharmacol; 2011 Nov; 25(11):1517-23. PubMed ID: 20855350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.